Detection of viable SARS-CoV-2 in deep respiratory specimens despite negative nasopharyngeal SARS-CoV-2 RT-PCR: Occult COVID-19 as an unsuspected cause of pulmonary infiltrates in immunocompromised patients

Avouac, 2021, Lancet Rheumatol, 3, e419, 10.1016/S2665-9913(21)00059-X Levavi, 2021, Impact of rituximab on COVID-19 outcomes, Ann Hematol, 100, 2805, 10.1007/s00277-021-04662-1 Cos Esquius, 2022, Severe COVID-19 pneumonia in Good syndrome with a favorable outcome, Clin Immunol, 235, 10.1016/j.clim.2021.108789 Calderón-Parra, 2022, Incidence, clinical presentation, relapses and outcome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients treated with anti-CD20 monoclonal antibodies, Clin Infect Dis, 74, 1786, 10.1093/cid/ciab700 Morel, 2022, Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab, Am J Transpl, 10.1111/ajt.17000 Ko, 2022, Emergence of SARS-CoV-2 spike mutations during prolonged infection in immunocompromised hosts, Microbiol Spectr, 10.1128/spectrum.00791-22 Cheung, 2022, Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19, Gut, 71, 226, 10.1136/gutjnl-2021-324280 Liang En, 2022, Enhanced infection-prevention measures including universal N95 usage and daily testing: the impact on SARS-CoV-2 transmission in cohorted hospital cubicles through successive Delta and Omicron waves, Clin Infect Dis Wee, 2021, Containment of COVID-19 and reduction in healthcare-associated respiratory viral infections through a multi-tiered infection control strategy, Infect Dis Health, 26, 123, 10.1016/j.idh.2020.11.004 Moor, 2021, Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study, Lancet Rheumatol, 3, e789, 10.1016/S2665-9913(21)00251-4 Furer, 2022, Predictors of immunogenic response to the BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases treated with rituximab, Vaccines, 10, 901, 10.3390/vaccines10060901 Mancon, 2022, Viro-immunological evaluation in an immunocompromised patient with long-lasting SARS-CoV-2 infection, Emerg Microbes Infect, 11, 786, 10.1080/22221751.2022.2045877 Yetmar, 2022, Outcomes of B-cell-depleted patients with coronavirus disease 2019 treated with antispike monoclonal antibodies, Open Forum Infect Dis, 9, 10.1093/ofid/ofac204